Clinical Trials Browser

Phase EARLY_PHASE1 × OTHER × Carcinoma, Squamous Cell × Clear all

NCT06819228 2025-10-03

Window Trial of Fluorescently Labeled Panitumumab (Panitumumab-IRDye800) in Head and Neck Cancer

Phase EARLY_PHASE1 Recruiting

Squamous Cell Carcinoma of Head and Neck, Carcinoma, Squamous Cell, Head and Neck Neoplasms, Laryngeal Diseases, Mouth Neoplasms, Tongue Neoplasms

NCT05678348 2025-08-17

Pyrimethamine as an Inhibitor of NRF2 in HPV-unrelated Locally Advanced Head and Neck Squamous Cell Carcinoma

Phase EARLY_PHASE1 Completed

Carcinoma, Squamous Cell, Head and Neck Neoplasms

NCT06782399 2025-01-17

SCC

Phase EARLY_PHASE1 Not yet recruiting

Carcinoma, Squamous Cell

NCT01755650 2023-09-13

Phase 0 of 18F FPM Using PET/CT in Patients With a Variety of Malignancies

Phase EARLY_PHASE1 Terminated

Carcinoma, Squamous Cell

NCT04839731 2023-02-13

Combination 5-FU / Calcipotriene Cream for SCCIS/SCC

Phase EARLY_PHASE1 Unknown

Carcinoma, Squamous Cell

NCT02593929 2017-06-08

Pharmacodynamic Effects and Predictive Biomarkers With Ruxolitinib in Operable Head and Neck Cancer

Phase EARLY_PHASE1 Withdrawn

Squamous Cell Carcinoma of Head and Neck, Carcinoma, Squamous Cell, Head and Neck Neoplasms